OBRIEN MORGAN E 4/A
4/A · Anterix Inc. · Filed Jun 8, 2022
Insider Transaction Report
Form 4/AAmended
Anterix Inc.ATEX
OBRIEN MORGAN E
DirectorVice Chairman of the Board
Transactions
- Award
Stock Option (Right to Buy)
2021-09-07+65,768→ 65,768 totalExercise: $60.92Exp: 2031-09-07→ Common Stock (65,768 underlying)
Footnotes (2)
- [F1]The prior Form 4 incorrectly reported the option grant for 65,595 shares.
- [F2]33 1/3% of the option shares vest and become exercisable on September 7, 2022 with the remaining shares vesting in 2 equal annual installments thereafter.